From discovery to innovation in animal health: meeting report of the second DIAH conference.

Authors

Johannes Charlier, Laetitia Cicchelero, Beatrice Vos, Juerg Baggenstoss, Hervé Poulet, Dieter Vancraeynest, Sven Arnouts

Published in

Biologicals : journal of the International Association of Biological Standardization. Volume 96. Pages 101919. Oct 22, 2026. Epub Oct 22, 2026.

Abstract

The second Discovery to Innovation in Animal Health (DIAH) Conference, held in Bruges, Belgium, brought together academic researchers, start-ups, industry, investors, regulators and funders to accelerate translation of scientific discoveries into veterinary products. The conference highlighted that successful translation requires early alignment between researchers and industry, sustained public-private funding and realistic market assessment. A clear target product profile, target-species proof-of-concept data, preliminary safety information, intellectual property protection, manufacturing plans and early regulatory dialogue were identified as central elements of an investable development package. Companion-animal markets are expanding rapidly in different segments, particularly products for age-related chronic diseases, behavioural disorders, and specialised diagnostics, while livestock innovation remains driven by prevention of infectious disease, antimicrobial and antiparasitic resistance, climate pressures and labour constraints. Emerging technologies presented included digital monitoring and artificial intelligence, alternatives to antimicrobials, novel antiparasitics, monoclonal antibodies and nanobodies, stem-cell and gene therapies, advanced vaccine platforms and mucosal delivery systems. Start-ups are increasingly important sources of innovation, but require credible commercial strategies, realistic valuation, scalable manufacturing and appropriate partnerships. Early engagement mechanisms offered by regulatory agencies can clarify evidence requirements and support development of novel therapies. Overall, DIAH demonstrated that multidisciplinary collaboration, shared terminology and early integration of scientific, regulatory, manufacturing and commercial perspectives are essential to de-risk innovation and deliver impactful animal health solutions.

PMID:
42913248
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.